Nov 10, 2022 Avenue Therapeutics Reports Third Quarter 2022 Financial Results and Recent Corporate Highlights
Nov 8, 2022 Avenue Therapeutics Completes the Acquisition of Baergic Bio and its Selective GABA-A α2/3 Receptor Positive Allosteric Modulator for the Treatment of Central Nervous System Disorders
